AI-Guided Action Path to Address the Clinical Execution Translation Gap

Kenneth I. Kaitin, PhD

Professor of Medicine & Senior Fellow, Tufts CSDD

Kenneth Kaitin is Professor of Medicine at Tufts University School of Medicine and Senior Fellow and Former Director of the Tufts Center for the Study of Drug Development. He is also an Advisory Professor at Shanghai Medical College at Fudan University in China, and serves on the faculties of the European Center for Pharmaceutical Medicine at the University of Basel, the American Course on Drug Development and Regulatory Science at the University of California, San Francisco, and the GMDP Academy-Kings College London Medical Affairs in Medicines Development Certification Program. Recognized internationally for his contributions to drug development policy and science, he consults, speaks, and writes on global trends in pharmaceutical development and has provided public testimony before the U.S. Congress. A former President of the Drug Information Association, he served as Editor-in-Chief of Expert Review of Clinical Pharmacology and as a consultant to the U.S. Department of Defense on bioterror countermeasures. He earned his BS from Cornell University and MS and PhD in pharmacology from the University of Rochester.

Kenneth A. Getz, MBA

Executive Director & Research Professor, Tufts CSDD

Ken Getz is the Executive Director and a research professor at the Tufts Center for the Study of Drug Development, Tufts University School of Medicine, where he conducts grant-funded research on pharmaceutical R&D management and execution, protocol design optimization, contract service provider and investigative site management, e-clinical technology and data usage, and patient and community engagement. He is chairman of CISCRP, a nonprofit he founded to raise public and patient clinical research literacy, and president of the Otsuka Patient Assistance Foundation. A well-known speaker and prolific author, he writes a bi-monthly column in Applied Clinical Trials and serves on several editorial boards. Ken received an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University and a bachelor's degree, Phi Beta Kappa, from Brandeis University. He is the founder of CenterWatch.

Moulik Shah

Founder & CEO, Maxis AI

Moulik Shah has been at the forefront of leveraging technology to transform pharmaceutical and life sciences clinical trials for over 20 years. A passionate healthcare technology entrepreneur, Moulik's dedication to improving clinical outcomes has fueled his vision of an integrated healthcare ecosystem based on effective use of data and analytics platforms. Under his leadership, Maxis AI has become a leading provider of clinical data and analytics, driving real-world impact in pharmaceutical and life sciences clinical trials.

Nicole Powell

Senior Vice President, Business Development, Maxis AI

Nicole, a strategic leader with over 17 years of experience in the clinical research industry, has consistently driven transformative revenue growth across diverse markets. Her expertise lies in building strong partnerships and steering corporate strategies that align with evolving industry needs. At Maxis AI, Nicole brings her insights and passion for collaboration to expand the reach of the Clinical Data Analytics Platform, helping clients streamline trials and achieve their objectives. She previously led business development and marketing at SDC and has presented at numerous industry conferences on tech-driven innovation in clinical research. She holds a BA from the University of Texas San Antonio and an MBA from Baylor University.